Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department for Digital, Culture, Media & Sport:
To ask His Majesty's Government what assessment they have made of the impact on viewers in Northern Ireland of switching off digital terrestrial television, in particular the impact on (1) access to UK and Irish public service broadcasting, and (2) cross-border licensing arrangements; and what discussions they have had with the government of Ireland and Irish regulators about that issue.
Answered by Baroness Twycross - Baroness in Waiting (HM Household) (Whip)
The Government is leading a project to assess the future of TV distribution beyond 2034 and is committed to maintaining cross border access for all audiences. The project will continue to engage with devolved governments to understand the distinct characteristics of broadcasting in Northern Ireland and the future of the Northern Ireland multiplex. The Stakeholder Forum benefited from the perspectives of organisations representing Northern Irish audiences including the Rural Services Network and Digital Poverty Alliance. Before any decision is made close consideration will be given to how any changes would impact audiences, especially those that are older, disabled, and on lower incomes.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department for Digital, Culture, Media & Sport:
To ask His Majesty's Government what modelling they have done of the impact of changes to digital terrestrial television on older people, disabled people and low income households in Northern Ireland, and what steps they will take to mitigate additional costs to those households.
Answered by Baroness Twycross - Baroness in Waiting (HM Household) (Whip)
The Government is leading a project to assess the future of TV distribution beyond 2034 and is committed to maintaining cross border access for all audiences. The project will continue to engage with devolved governments to understand the distinct characteristics of broadcasting in Northern Ireland and the future of the Northern Ireland multiplex. The Stakeholder Forum benefited from the perspectives of organisations representing Northern Irish audiences including the Rural Services Network and Digital Poverty Alliance. Before any decision is made close consideration will be given to how any changes would impact audiences, especially those that are older, disabled, and on lower incomes.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department for Digital, Culture, Media & Sport:
To ask His Majesty's Government whether the remit of the Future of TV Distribution Stakeholder Forum includes an assessment of (1) affordability and social exclusion risks, and (2) regional impacts, including impacts on the Northern Ireland multiplex.
Answered by Baroness Twycross - Baroness in Waiting (HM Household) (Whip)
The Government is leading a project to assess the future of TV distribution beyond 2034 and is committed to maintaining cross border access for all audiences. The project will continue to engage with devolved governments to understand the distinct characteristics of broadcasting in Northern Ireland and the future of the Northern Ireland multiplex. The Stakeholder Forum benefited from the perspectives of organisations representing Northern Irish audiences including the Rural Services Network and Digital Poverty Alliance. Before any decision is made close consideration will be given to how any changes would impact audiences, especially those that are older, disabled, and on lower incomes.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department for Environment, Food and Rural Affairs:
To ask His Majesty's Government when they plan to publish the post-implementation review of the Reduction and Prevention of Agricultural Diffuse Pollution (England) Regulations 2018.
Answered by Baroness Hayman of Ullock - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
We will publish the statutory report into this important regulation (known as the Farming rules for Water) in due course.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to prioritise (1) dermatology, (2) allergy, and (3) immunology, as clinical specialties within future modern service frameworks.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Modern service frameworks will define an aspirational, long-term outcome goal for a major condition and will then identify the best evidenced interventions and the support for delivery.
The Government will consider clinical specialities for future waves of modern service frameworks, including allergy, dermatology, which includes chronic spontaneous urticaria (CSU), and immunology. The criteria for determining other conditions for future modern service frameworks will be based on disease burden, care variation, economic impact, and where there is potential for rapid and significant improvements in the quality of care and productivity.
The Department recognises the potential benefits of virtual clinics in improving access to specialist care for conditions like CSU. A central part of our 10-Year Health Plan is moving care closer to home, and we recognise that we need to do this while retaining access to specialist support. Trusts should provide the infrastructure and resources to facilitate virtual consultations, but this should not replace face-to-face care where it is more appropriate, dependent on clinical need, or preferred by individual patients.
NHS England’s service specification for specialised dermatology services for adults and children is designed to reduce regional disparities in care for CSU by setting consistent national standards for diagnosis, treatment, and follow-up. The specification ensures that all patients, regardless of location, have access to evidence-based interventions and specialist expertise, including advanced therapies where clinically appropriate. The specification addresses historical variations in service provision and supports equitable access across integrated care systems. This approach helps to improve outcomes for patients with CSU and ensures a more uniform level of care throughout England.
Additionally, NHS England’s Getting It Right First Time programme is working to improve capacity and waiting times through its established Further Faster programme. This programme brings together hospital trust clinicians and operational teams with the challenge of collectively going ‘further and faster’ to transform patient pathways, reduce unnecessary follow-up outpatient appointments, and improve access and waiting times for patients.
A Further Faster handbook for dermatology has been produced, to share best practice and support National Health Service dermatology teams to reduce the number of Did Not Attend appointments, reduce unnecessary follow ups and, where appropriate, reduce the number of outpatient appointments by booking patients straight to tests, helping to free up capacity for patients in need of specialist dermatology services.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the use of virtual clinics for chronic spontaneous urticaria to reduce waiting times and improve patient outcomes.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Modern service frameworks will define an aspirational, long-term outcome goal for a major condition and will then identify the best evidenced interventions and the support for delivery.
The Government will consider clinical specialities for future waves of modern service frameworks, including allergy, dermatology, which includes chronic spontaneous urticaria (CSU), and immunology. The criteria for determining other conditions for future modern service frameworks will be based on disease burden, care variation, economic impact, and where there is potential for rapid and significant improvements in the quality of care and productivity.
The Department recognises the potential benefits of virtual clinics in improving access to specialist care for conditions like CSU. A central part of our 10-Year Health Plan is moving care closer to home, and we recognise that we need to do this while retaining access to specialist support. Trusts should provide the infrastructure and resources to facilitate virtual consultations, but this should not replace face-to-face care where it is more appropriate, dependent on clinical need, or preferred by individual patients.
NHS England’s service specification for specialised dermatology services for adults and children is designed to reduce regional disparities in care for CSU by setting consistent national standards for diagnosis, treatment, and follow-up. The specification ensures that all patients, regardless of location, have access to evidence-based interventions and specialist expertise, including advanced therapies where clinically appropriate. The specification addresses historical variations in service provision and supports equitable access across integrated care systems. This approach helps to improve outcomes for patients with CSU and ensures a more uniform level of care throughout England.
Additionally, NHS England’s Getting It Right First Time programme is working to improve capacity and waiting times through its established Further Faster programme. This programme brings together hospital trust clinicians and operational teams with the challenge of collectively going ‘further and faster’ to transform patient pathways, reduce unnecessary follow-up outpatient appointments, and improve access and waiting times for patients.
A Further Faster handbook for dermatology has been produced, to share best practice and support National Health Service dermatology teams to reduce the number of Did Not Attend appointments, reduce unnecessary follow ups and, where appropriate, reduce the number of outpatient appointments by booking patients straight to tests, helping to free up capacity for patients in need of specialist dermatology services.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to address regional disparities in chronic spontaneous urticaria service provision and capacity across England.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Modern service frameworks will define an aspirational, long-term outcome goal for a major condition and will then identify the best evidenced interventions and the support for delivery.
The Government will consider clinical specialities for future waves of modern service frameworks, including allergy, dermatology, which includes chronic spontaneous urticaria (CSU), and immunology. The criteria for determining other conditions for future modern service frameworks will be based on disease burden, care variation, economic impact, and where there is potential for rapid and significant improvements in the quality of care and productivity.
The Department recognises the potential benefits of virtual clinics in improving access to specialist care for conditions like CSU. A central part of our 10-Year Health Plan is moving care closer to home, and we recognise that we need to do this while retaining access to specialist support. Trusts should provide the infrastructure and resources to facilitate virtual consultations, but this should not replace face-to-face care where it is more appropriate, dependent on clinical need, or preferred by individual patients.
NHS England’s service specification for specialised dermatology services for adults and children is designed to reduce regional disparities in care for CSU by setting consistent national standards for diagnosis, treatment, and follow-up. The specification ensures that all patients, regardless of location, have access to evidence-based interventions and specialist expertise, including advanced therapies where clinically appropriate. The specification addresses historical variations in service provision and supports equitable access across integrated care systems. This approach helps to improve outcomes for patients with CSU and ensures a more uniform level of care throughout England.
Additionally, NHS England’s Getting It Right First Time programme is working to improve capacity and waiting times through its established Further Faster programme. This programme brings together hospital trust clinicians and operational teams with the challenge of collectively going ‘further and faster’ to transform patient pathways, reduce unnecessary follow-up outpatient appointments, and improve access and waiting times for patients.
A Further Faster handbook for dermatology has been produced, to share best practice and support National Health Service dermatology teams to reduce the number of Did Not Attend appointments, reduce unnecessary follow ups and, where appropriate, reduce the number of outpatient appointments by booking patients straight to tests, helping to free up capacity for patients in need of specialist dermatology services.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what plans they have to include chronic spontaneous urticaria within a future modern service framework.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
Modern service frameworks will define an aspirational, long-term outcome goal for a major condition and will then identify the best evidenced interventions and the support for delivery.
The Government will consider clinical specialities for future waves of modern service frameworks, including allergy, dermatology, which includes chronic spontaneous urticaria (CSU), and immunology. The criteria for determining other conditions for future modern service frameworks will be based on disease burden, care variation, economic impact, and where there is potential for rapid and significant improvements in the quality of care and productivity.
The Department recognises the potential benefits of virtual clinics in improving access to specialist care for conditions like CSU. A central part of our 10-Year Health Plan is moving care closer to home, and we recognise that we need to do this while retaining access to specialist support. Trusts should provide the infrastructure and resources to facilitate virtual consultations, but this should not replace face-to-face care where it is more appropriate, dependent on clinical need, or preferred by individual patients.
NHS England’s service specification for specialised dermatology services for adults and children is designed to reduce regional disparities in care for CSU by setting consistent national standards for diagnosis, treatment, and follow-up. The specification ensures that all patients, regardless of location, have access to evidence-based interventions and specialist expertise, including advanced therapies where clinically appropriate. The specification addresses historical variations in service provision and supports equitable access across integrated care systems. This approach helps to improve outcomes for patients with CSU and ensures a more uniform level of care throughout England.
Additionally, NHS England’s Getting It Right First Time programme is working to improve capacity and waiting times through its established Further Faster programme. This programme brings together hospital trust clinicians and operational teams with the challenge of collectively going ‘further and faster’ to transform patient pathways, reduce unnecessary follow-up outpatient appointments, and improve access and waiting times for patients.
A Further Faster handbook for dermatology has been produced, to share best practice and support National Health Service dermatology teams to reduce the number of Did Not Attend appointments, reduce unnecessary follow ups and, where appropriate, reduce the number of outpatient appointments by booking patients straight to tests, helping to free up capacity for patients in need of specialist dermatology services.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether the NHS 10-year workforce plan will consider and prioritise the recruitment, development and retention of GPs and clinicians with extended roles in allergy and dermatology.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to publishing a 10 Year Workforce Plan to set out action to create a workforce ready to deliver the transformed service set out in the 10-Year Health Plan. The 10 Year Workforce Plan will ensure the National Health Service has the right people in the right places, with the right skills to care for patients, when they need it. We are working through how the plan will articulate the changes for different professional groups.
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the report by the Food Standards Agency, Safety of Nitrates and Nitrites as Food Additives, published on 1 October; what discussions they have had with the FSA about publishing the correspondence, criteria and communications relating to the preparation of that review; and whether they plan to commission a comprehensive multidisciplinary study of the safety of nitrites in processed meats.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
The Food Standards Agency’s (FSA) review of nitrates and nitrites as food additives is an important piece of work that summarises recent evidence from human studies to inform policy decisions.
To maintain transparency, the full report, including its scope, search criteria, and details of the external contract, has been published on Government websites. This allows stakeholders and the public to see exactly how the review was conducted and how conclusions were reached.
The published report clearly sets out the methodology and criteria used, providing clarity and confidence in the process. The FSA does not routinely publish internal correspondence or preparatory communications, due to the potential inclusion of commercially sensitive or personal information. However, the report itself provides full transparency on the evidence base and decision-making approach. There have been no discussions on changing this approach.
There are no plans to commission a broader multidisciplinary study. Existing permitted nitrite levels are based on robust international risk assessments and remain appropriate to protect public health. Commissioning a new study would require significant resource and is not justified without new evidence indicating a change in risk.